215 related articles for article (PubMed ID: 24173373)
1. Curcumin regulates the metabolism of low density lipoproteins by improving the C-to-U RNA editing efficiency of apolipoprotein B in primary rat hepatocytes.
Tian N; Li X; Luo Y; Han Z; Li Z; Fan C
Mol Med Rep; 2014 Jan; 9(1):132-6. PubMed ID: 24173373
[TBL] [Abstract][Full Text] [Related]
2. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.
Hughes SD; Rouy D; Navaratnam N; Scott J; Rubin EM
Hum Gene Ther; 1996 Jan; 7(1):39-49. PubMed ID: 8825867
[TBL] [Abstract][Full Text] [Related]
3. Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.
Hersberger M; Patarroyo-White S; Qian X; Arnold KS; Rohrer L; Balestra ME; Innerarity TL
Biochem J; 2003 Jan; 369(Pt 2):255-62. PubMed ID: 12374571
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein B mRNA editing and the reduction in synthesis and secretion of the atherogenic risk factor, apolipoprotein B100 can be effectively targeted through TAT-mediated protein transduction.
Yang Y; Ballatori N; Smith HC
Mol Pharmacol; 2002 Feb; 61(2):269-76. PubMed ID: 11809850
[TBL] [Abstract][Full Text] [Related]
5. Curcumin modulates the apolipoprotein B mRNA editing by coordinating the expression of cytidine deamination to uridine editosome components in primary mouse hepatocytes.
He P; Tian N
Korean J Physiol Pharmacol; 2019 May; 23(3):181-189. PubMed ID: 31080349
[TBL] [Abstract][Full Text] [Related]
6. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors.
Qian X; Balestra ME; Yamanaka S; Borén J; Lee I; Innerarity TL
Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):1013-20. PubMed ID: 9633945
[TBL] [Abstract][Full Text] [Related]
7. Insulin increases expression of apobec-1, the catalytic subunit of the apolipoprotein B mRNA editing complex in rat hepatocytes.
von Wronski MA; Hirano KI; Cagen LM; Wilcox HG; Raghow R; Thorngate FE; Heimberg M; Davidson NO; Elam MB
Metabolism; 1998 Jul; 47(7):869-73. PubMed ID: 9667237
[TBL] [Abstract][Full Text] [Related]
8. Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and watanabe heritable hyperlipidemic rabbits.
Greeve J; Jona VK; Chowdhury NR; Horwitz MS; Chowdhury JR
J Lipid Res; 1996 Sep; 37(9):2001-17. PubMed ID: 8895066
[TBL] [Abstract][Full Text] [Related]
9. Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity.
Siddiqui JF; Van Mater D; Sowden MP; Smith HC
Exp Cell Res; 1999 Oct; 252(1):154-64. PubMed ID: 10502408
[TBL] [Abstract][Full Text] [Related]
10. The editosome for cytidine to uridine mRNA editing has a native complexity of 27S: identification of intracellular domains containing active and inactive editing factors.
Sowden MP; Ballatori N; Jensen KL; Reed LH; Smith HC
J Cell Sci; 2002 Mar; 115(Pt 5):1027-39. PubMed ID: 11870221
[TBL] [Abstract][Full Text] [Related]
11. Acute modulation of the extent of apoB mRNA editing and the relative rates of syntheses of apoB48 and apoB100 in cultured rat hepatocytes by osmotic and other stress stimuli.
McCahill A; Lankester DJ; Park BS; Price NT; Zammit VA
Mol Cell Biochem; 2000 May; 208(1-2):77-87. PubMed ID: 10939631
[TBL] [Abstract][Full Text] [Related]
12. Metabolic regulation of apoB mRNA editing is associated with phosphorylation of APOBEC-1 complementation factor.
Lehmann DM; Galloway CA; Sowden MP; Smith HC
Nucleic Acids Res; 2006; 34(11):3299-308. PubMed ID: 16820530
[TBL] [Abstract][Full Text] [Related]
13. Re-editing the paradigm of Cytidine (C) to Uridine (U) RNA editing.
Fossat N; Tam PP
RNA Biol; 2014; 11(10):1233-7. PubMed ID: 25585043
[TBL] [Abstract][Full Text] [Related]
14. Metabolic regulation of APOBEC-1 complementation factor trafficking in mouse models of obesity and its positive correlation with the expression of ApoB protein in hepatocytes.
Galloway CA; Ashton J; Sparks JD; Mooney RA; Smith HC
Biochim Biophys Acta; 2010 Nov; 1802(11):976-85. PubMed ID: 20541607
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice.
Oka K; Kobayashi K; Sullivan M; Martinez J; Teng BB; Ishimura-Oka K; Chan L
J Biol Chem; 1997 Jan; 272(3):1456-60. PubMed ID: 8999814
[TBL] [Abstract][Full Text] [Related]
16. Mouse and other rodent models of C to U RNA editing.
Blanc V; Davidson NO
Methods Mol Biol; 2011; 718():121-35. PubMed ID: 21370045
[TBL] [Abstract][Full Text] [Related]
17. Calcium increases apolipoprotein B mRNA editing.
Chen Z; Eggerman TL; Potosky D; Arborati M; Patterson AP
Biochem Biophys Res Commun; 2000 Oct; 277(1):221-7. PubMed ID: 11027667
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein B RNA sequence 3' of the mooring sequence and cellular sources of auxiliary factors determine the location and extent of promiscuous editing.
Sowden MP; Eagleton MJ; Smith HC
Nucleic Acids Res; 1998 Apr; 26(7):1644-52. PubMed ID: 9512534
[TBL] [Abstract][Full Text] [Related]
19. RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA.
Chester A; Scott J; Anant S; Navaratnam N
Biochim Biophys Acta; 2000 Nov; 1494(1-2):1-13. PubMed ID: 11072063
[TBL] [Abstract][Full Text] [Related]
20. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1.
Nakamuta M; Chang BH; Zsigmond E; Kobayashi K; Lei H; Ishida BY; Oka K; Li E; Chan L
J Biol Chem; 1996 Oct; 271(42):25981-8. PubMed ID: 8824235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
